139
Views
18
CrossRef citations to date
0
Altmetric
Review

Cysteamine hydrochloride eye drop solution for the treatment of corneal cystine crystal deposits in patients with cystinosis: an evidence-based review

&
Pages 227-236 | Published online: 24 Jan 2018

References

  • GahlWABashanNTietzeFBernardiniISchulmanJDCystine transport is defective in isolated leukocyte lysosomes from patients with cystinosisScience19822174566126312657112129
  • GahlWAThoeneJGSchneiderJACystinosisN Engl J Med2002347211112112110740
  • KalatzisVAntignacCNew aspects of the pathogenesis of cystinosisPediatr Nephrol200318320721512644911
  • GahlWABalogJZKletaRNephropathic cystinosis in adults: natural history and effects of oral cysteamine therapyAnn Intern Med2007147424225017709758
  • WilmerMJEmmaFLevtchenkoENThe pathogenesis of cystinosis: mechanisms beyond cystine accumulationAm J Physiol Renal Physiol20102995F905F91620826575
  • ForestierLJeanGAttardMMolecular characterization of CTNS deletions in nephropathic cystinosis: development of a PCR-based detection assayAm J Hum Genet199965235335910417278
  • TouchmanJWAniksterYDietrichNLThe genomic region encompassing the nephropathic cystinosis gene (CTNS): complete sequencing of a 200-kb segment and discovery of a novel gene within the common cystinosis-causing deletionGenome Res200010216517310673275
  • TownMJeanGCherquiSA novel gene encoding an integral membrane protein is mutated in nephropathic cystinosisNat Genet19981843193249537412
  • ElmonemMAVeysKRSolimanNAvan DyckMvan den HeuvelLPLevtchenkoECystinosis: a reviewOrphanet J Rare Dis2016114727102039
  • ShotelersukVLarsonDAniksterYCTNS mutations in an American-based population of cystinosis patientsAm J Hum Genet1998635135213629792862
  • KalatzisVCherquiSJeanGCharacterization of a putative founder mutation that accounts for the high incidence of cystinosis in BrittanyJ Am Soc Nephrol200112102170217411562417
  • McGowan-JordanJStoddardKPodolskyLMolecular analysis of cystinosis: probable Irish origin of the most common French Canadian mutationEur J Hum Genet19997667167810482956
  • ElmonemMAMahmoudIGMehaneyDALysosomal storage disorders in Egyptian childrenIndian J Pediatr201683880581326830282
  • TopalogluRVilbouxTCoskunTGenetic basis of cystinosis in Turkish patients: a single-center experiencePediatr Nephrol201227111512121786142
  • AniksterYLuceroCTouchmanJWIdentification and detection of the common 65-kb deletion breakpoint in the nephropathic cystinosis gene (CTNS)Mol Genet Metab199966211111610068513
  • AttardMJeanGForestierLSeverity of phenotype in cystinosis varies with mutations in the CTNS gene: predicted effect on the model of cystinosinHum Mol Genet19998132507251410556299
  • KalatzisVNevoNCherquiSGasnierBAntignacCMolecular pathogenesis of cystinosis: effect of CTNS mutations on the transport activity and subcellular localization of cystinosinHum Mol Genet200413131361137115128704
  • TsilouEZhouMGahlWSievingPCChanCCOphthalmic manifestations and histopathology of infantile nephropathic cystinosis: report of a case and review of the literatureSurv Ophthalmol20075219710517212992
  • ThoeneJGA review of the role of enhanced apoptosis in the pathophys-iology of cystinosisMol Genet Metab200792429229817728168
  • BoisEFeingoldJFrenayPBriardMLInfantile cystinosis in France: genetics, incidence, geographic distributionJ Med Genet19761364344381018302
  • AldahmeshMAHumeidanAAlmojalliHACharacterization of CTNS mutations in Arab patients with cystinosisOphthalmic Genet200930418518919852576
  • SolimanNABazaraaHMAbdel HamidRHBadawiNNephropathic cystinosis in a developing country: the Egyptian experienceSaudi J Kidney Dis Transpl201324114714923354215
  • KitnarongNOsuwannaratanaPKamchaisatianWNamtongthaiPMetheetrairutAOcular manifestations in adolescent cystinosis: case report in ThailandJ Med Assoc Thai200588452152616146258
  • HutchessonACBundeySPreeceMAHallSKGreenAA comparison of disease and gene frequencies of inborn errors of metabolism among different ethnic groups in the West Midlands, UKJ Med Genet19983553663709610798
  • De BraekeleerMHereditary disorders in Saguenay-Lac-St-Jean (Quebec, Canada)Hum Hered19914131411461937486
  • ManzFGretzNCystinosis in the Federal Republic of Germany. Coordination and analysis of the dataJ Inherit Metab Dis19858124
  • MeiklePJHopwoodJJClagueAECareyWFPrevalence of lysosomal storage disordersJAMA199928132492549918480
  • HultMDarinNvon DöbelnUMånssonJEEpidemiology of lysosomal storage diseases in SwedenActa Paediatr2014103121258126325274184
  • EbbesenFMygindKIHolckFInfantile nephropatic cystinosis in DenmarkDan Med Bull1976235216222975942
  • NakhaiiSHoomanNOtukeshHGastrointestinal manifestations of nephropathic cystinosis in childrenIran J Kidney Dis20093421822119841525
  • VaisbichMHKochVHReport of a Brazilian multicenter study on nephropathic cystinosisNephron Clin Pract20101141c12c1819816039
  • Kaiser-KupferMICarusoRCMinklerDSGahlWALong-term ocular manifestations in nephropathic cystinosisArch Ophthalmol198610457067113518682
  • TsilouETRubinBIReedGFIwataFGahlWKaiser-KupferMIAge-related prevalence of anterior segment complications in patients with infantile nephropathic cystinosisCornea200221217317611862089
  • KocaboraMSOzbilenKTAltunsoyMAhishaliBTaskapiliMClinicopathological features of ocular cystinosisClin Exp Ophthalmol200836877878119128385
  • BishopROcular complications of infantile nephropathic cystinosisJ Pediatr2017183SS19S2128343471
  • TsilouERubinBIReedGNephropathic cystinosis: posterior segment manifestations and effects of cysteamine therapyOphthalmology200611361002100916603246
  • KatzBMellesRBSchneiderJAContrast sensitivity function in neph-ropathic cystinosisArch Ophthalmol198710512166716693689189
  • GretzNManzFAugustinRSurvival time in cystinosis. A collaborative studyProc Eur Dial Transplant Assoc1983195825896878257
  • AlmondPSMatasAJNakhlehRERenal transplantation for infantile cystinosis: long-term follow-upJ Pediatr Surg19932822322388437088
  • Van StralenKJEmmaFJagerKJImprovement in the renal prognosis in nephropathic cystinosisClin J Am Soc Nephrol20116102485249121868618
  • SpicerRAClaytonPAMcTaggartSJZhangGYAlexanderSIPatient and graft survival following kidney transplantation in recipients with cystinosis: a cohort studyAm J Kidney Dis201565117217325240261
  • LewisMAShawJSinhaMAdalatSHussainFInwardCUK Renal Registry 11th Annual Report (December 2008): Chapter 13 Demography of the UK paediatric renal replacement therapy populationNephron Clin Pract2009111Suppl 1c257c26719542701
  • CohenCCharbitMChadefaux-VekemansBExcellent long-term outcome of renal transplantation in cystinosis patientsOrphanet J Rare Dis2015109026208493
  • Bertholet-ThomasABacchettaJTasicVCochatPNephropathic cystinosis – a gap between developing and developed nationsN Engl J Med2014370141366136724693916
  • Kaiser-KupferMIFujikawaLKuwabaraTJainSGahlWARemoval of corneal crystals by topical cysteamine in nephropathic cystinosisN Engl J Med1987316137757593821824
  • KatzBMellesRBSchneiderJACrystal deposition following keratoplasty in nephropathic cystinosisArch Ophthalmol19891071217271728
  • SimpsonJLNienCJFlynnKJJesterJVEvaluation of topical cysteamine therapy in the CTNS(-/-) knockout mouse using in vivo confocal microscopyMol Vis2011172649265422065917
  • ThoeneJGOshimaRGCrawhallJCOlsonDLSchneiderJACystinosis. Intracellular cystine depletion by aminothiols in vitro and in vivoJ Clin Invest1976581180189932205
  • PescinaSCarraFPadulaCSantiPNicoliSEffect of pH and penetration enhancers on cysteamine stability and trans-corneal transportEur J Pharm Biopharm201610717117927395395
  • HuynhNGahlWABishopRJCysteamine ophthalmic solution 0.44% for the treatment of corneal cystine crystals in cystinosisExpert Rev Ophthalmol201384341345
  • McKenzieBKayGMatthewsKHKnottRCairnsDPreformulation of cysteamine gels for treatment of the ophthalmic complications in cystinosisInt J Pharm20165151–257558227771488
  • HsuKHFentzkeRCChauhanAFeasibility of corneal drug delivery of cysteamine using vitamin E modified silicone hydrogel contact lensesEur J Pharm Biopharm2013853 Pt A53154023665502
  • BozdağSGümüşKGümüşOUnlüNFormulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosisEur J Pharm Biopharm200870126026918590953
  • BuchanBKayGHeneghanAMatthewsKHCairnsDGel formulations for treatment of the ophthalmic complications in cystinosisInt J Pharm20103921–219219720382212
  • MarcanoDCShinCSLeeBSynergistic cysteamine delivery nanowafer as an efficacious treatment modality for corneal cystinosisMol Pharm201613103468347727571217
  • ShamsFLivingstoneIOladiwuraDRamaeshKTreatment of corneal cystine crystal accumulation in patients with cystinosisClin Ophthalmol201482077208425336909
  • Kaiser-KupferMIGazzoMADatilesMBCarusoRCKuehlEMGahlWAA randomized placebo-controlled trial of cysteamine eye drops in nephropathic cystinosisArch Ophthalmol199010856896932185723
  • JonesNPPostlethwaiteRJNobleJLClearance of corneal crystals in nephropathic cystinosis by topical cysteamine 0.5%Br J Ophthalmol19917553113122036352
  • BradburyJADanjouxJPVollerJSpencerMBrocklebankTA randomised placebo-controlled trial of topical cysteamine therapy in patients with nephropathic cystinosisEye (Lond)19915Pt 67557601800180
  • IwataFKuehlEMReedGFMcCainLMGahlWAKaiser-KupferMIA randomized clinical trial of topical cysteamine disulfide (cystamine) versus free thiol (cysteamine) in the treatment of corneal cystine crystals in cystinosisMol Genet Metab19986442372429758713
  • TsilouETThompsonDLindbladASA multicentre randomised double masked clinical trial of a new formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosisBr J Ophthalmol2003871283112488257
  • Al-HemidanAShoughySSKozakITabbaraKFEfficacy of topical cysteamine in nephropathic cystinosisBr J Ophthalmol201710191234123728057644
  • LabbéABaudouinCDeschênesGA new gel formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis: the Cystadrops OCT-1 studyMol Genet Metab2014111331432024440466
  • LiangHLabbéALe MouhaërJPlissonCBaudouinCA new viscous cysteamine eye drops treatment for ophthalmic cystinosis: an open-label randomized comparative phase III pivotal studyInvest Ophthalmol Vis Sci20175842275228328426870
  • www.ema.europa.eu/ema [homepage on the Internet]Assessment report: Dropcys Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/004038/WC500210937.pdfAccessed October 7, 2017
  • HsuanJDHardingJJBronAJThe penetration of topical cysteamine into the human eyeJ Ocul Pharmacol Ther19961244995028951686